Skip to the page

Data / Drug companies / Ropinirole

Ropinirole: 20 companies and 111 products in the FDA NDC directory

Ropinirole is listed in the FDA National Drug Code Directory by 20 companies, with 111 products in commercial distribution. 111 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, film coated, extended release; tablet, extended release, and the newest product started marketing on July 6, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
20
Products
111
Generic (ANDA) products
111 (100.0%)
Application numbers
10
Routes
Oral
openFDA record search
api.fda.gov

Companies that list ropinirole

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Alembic Pharmaceuticals Inc.12tablet, film coated; tablet, film coated, extended releaseGeneric drugs (ANDA)June 20, 2020
Alembic Pharmaceuticals Limited12tablet, film coated; tablet, film coated, extended releaseGeneric drugs (ANDA)September 12, 2013
Bryant Ranch Prepack10tablet, film coatedGeneric drugs (ANDA)September 15, 2022
Accord Healthcare Inc.7tablet, film coatedGeneric drugs (ANDA)October 17, 2018
Bionpharma Inc.7tablet, film coatedGeneric drugs (ANDA)September 15, 2022
Glenmark Pharmaceuticals Inc., USA7tablet, film coatedGeneric drugs (ANDA)February 25, 2010
Marlex Pharmaceuticals, Inc.7tablet, film coatedGeneric drugs (ANDA)March 15, 2019
Bryant Ranch Prepack6tablet, extended release; tablet, film coatedGeneric drugs (ANDA)November 10, 2025
Actavis Pharma, Inc.5tablet, film coated, extended releaseGeneric drugs (ANDA)August 23, 2012
Dr. Reddy's Laboratories Limited5tablet, film coated, extended releaseGeneric drugs (ANDA)June 6, 2012
Elite Laboratories, Inc.5tablet, extended releaseGeneric drugs (ANDA)November 10, 2025
Solco Healthcare US, LLC5tablet, extended releaseGeneric drugs (ANDA)March 22, 2022
A-S Medication Solutions4tablet, film coatedGeneric drugs (ANDA)September 15, 2022
Asclemed USA Inc.4tablet, film coatedGeneric drugs (ANDA)September 15, 2022
Direct_Rx4tablet, film coatedGeneric drugs (ANDA)June 22, 2023
Remedyrepack Inc.4tablet, film coatedGeneric drugs (ANDA)March 25, 2025
Cardinal Health 107, LLC2tablet, film coatedGeneric drugs (ANDA)October 1, 2014
Coupler LLC2tablet, film coatedGeneric drugs (ANDA)January 29, 2025
Major Pharmaceuticals2tablet, film coatedGeneric drugs (ANDA)October 1, 2014
Preferred Pharmaceuticals Inc.1tablet, film coatedGeneric drugs (ANDA)July 6, 2026

Dosage forms

Dosage formProductsShare
Tablet, film coated7668.5%
Tablet, film coated, extended release2018%
Tablet, extended release1513.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)111100%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.